Seller record · fellahealth.com

Fella Health

Recorded September 2026 · Standard v1.1

Fails 2 of 8 criteria. S5, analytical documentation: No certificate of analysis, chromatogram or lot document is linked on any page read, and the treatments page asserts quality without naming a laboratory, a figure or a method. 1 more criterion also fails; see the table below.

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A telehealth weight-loss and hormone program marketed to men, with clinical services delivered by a named medical group. It names two partner pharmacies with street addresses, and it prints no figure for its GLP-1 program.

Operating entity Aios Inc.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	fellahealth.com/treatments
S2	Prescription gating	PASS	fellahealth.com/fella-promo-quiz-nla
S3	Pharmacy identification	PASS	fellahealth.com/faq
S4	Compounding disclosure	PASS	fellahealth.com/treatments
S5	Analytical documentation	FAIL	fellahealth.com/treatments
S6	Business address	PASS	fellahealth.com
S7	Price disclosure	FAIL	fellahealth.com/treatments
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSThe treatments page states that a provider decides whether a compounded prescription is appropriate, and the telehealth consent names Fella Medical Group as the prescribing group.Source: fellahealth.com/treatments.

S2PASSThe order path was walked and stopped at the eighth intake screen, which demanded a date of birth under a stated minimum age requirement.Source: fellahealth.com/fella-promo-quiz-nla.

S3PASSThe frequently asked questions page names two partner pharmacies with full street addresses and telephone numbers: Strive Pharmacy in Gilbert, Arizona and Red Rock Home Pharmacy in Springville, Utah.Source: fellahealth.com/faq.

S4PASSThe treatments page carries the words compounded and not FDA-approved together in visible body text, outside the terms of use.Source: fellahealth.com/treatments.

S5FAILNo certificate of analysis, chromatogram or lot document is linked on any page read, and the treatments page asserts quality without naming a laboratory, a figure or a method.Source: fellahealth.com/treatments.

S6PASSA street address with a suite number is printed in the footer of every page captured, beside the copyright line.Source: fellahealth.com.

S7FAILThe GLP-1 program price is printed nowhere, and the link labeled pricing resolves to the eligibility quiz; four other treatments do print monthly figures, from 45 dollars to 149 dollars per month.Source: fellahealth.com/treatments.

S8PASSNo letter names the entity in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded GLP-1 plans, compounded microdose plans, enclomiphene, metformin, rapamycin, NAD+.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.